Marie Christine Wulff Westergaard
Marie Christine Wulff Westergaard
1Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
1,
Rikke Andersen
Rikke Andersen
1Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
2Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
1,2,
Chloé Chong
Chloé Chong
3Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland
4Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland
3,4,
Julie Westerlin Kjeldsen
Julie Westerlin Kjeldsen
1Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
2Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
1,2,
Magnus Pedersen
Magnus Pedersen
1Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
2Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
1,2,
Christina Friese
Christina Friese
1Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
1,
Thomas Hasselager
Thomas Hasselager
5Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
5,
Henrik Lajer
Henrik Lajer
6Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
6,
George Coukos
George Coukos
3Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland
4Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland
3,4,
Michal Bassani-Sternberg
Michal Bassani-Sternberg
3Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland
4Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland
3,4,
Marco Donia
Marco Donia
1Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
2Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
1,2,#,
Inge Marie Svane
Inge Marie Svane
1Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
2Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
1,2,✉,#
1Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
2Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
3Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland
4Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland
5Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
6Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Subject terms: Tumour immunology, Ovarian cancer, Ovarian cancer, Tumour immunology
© Cancer Research UK 2019
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
